Novo Nordisk A/S is poised for long-term growth despite job cuts and margin resets. Click here to find out why NVO stock is a ...

The rapid rise in prescriptions for GLP-1 weight loss drugs had a muted effect on Delaware health insurers’ spending thanks ...

CVS Caremark is facing a lawsuit after being accused of pointing patients to use a weight loss drug called Wegovy and for ...

“Obesity is a complex disease,” says Shauna Levy, medical director of the Tulane School of Medicine’s Bariatric and Weight Loss Center. “The fact is that not everyone responds to the same treatments, ...

As evidence grows supporting the potential health benefits of obesity drugs like Novo Nordisk’s Wegovy and Eli Lilly & Co.’s ...

The post As Insurers Struggle With GLP-1 Costs, Some Seek To Wean Patients Off appeared first on Katie Couric Media. Innotox is like Botox, but without FDA approval or a whole lot of other important ...

Eli Lilly (NYSE:LLY) said on Monday that its late-stage trial testing Jaypirca (pirtobrutinib), compared with chemoimmunotherapy, in patients with chronic lymphocytic leukemia or small lymphocytic ...

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli ...

As people come off GLP-1 medications like Ozempic and Wegovy, Virtua Health and other companies are pushing behavior-based weight management programs.

From possible National Guard deployments to the resignation of Northwestern's president, we break down the week’s biggest ...